Andrew Mazzone, MD
Urology · Twin Falls, IDNPI 1619402286
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 124 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Boston Scientific accounts for 86.4% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $986 and has fallen 91.5% since, to $84 in 2025. That places this record below the midpoint for urology clinicians in ID, where the typical reported total is $3,075.
Across 124 payments — averaging $23.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Coloplast$133
- Biocompatibles, Inc.$107
- Procept Biorobotics Corporation$45
- AstraZeneca$35
- Johnson & Johnson$30
- plus $47 from 2 others
What the payments were for
- Food & beverage$2,89299%
- Education$351%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 112 | $2,529 |
| Coloplast | 5 | $133 |
| Biocompatibles, Inc. | 1 | $107 |
| Procept Biorobotics Corporation | 2 | $45 |
| AstraZeneca | 1 | $35 |
| Johnson & Johnson | 1 | $30 |
| Cook Medical LLC | 1 | $28 |
| Medtronic | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LithoVue$348
- TACTRA$111
- VISUAL-ICE$107
- GENERAL KIDNEY STONE DISEASE$101
How this compares
$2,927 in reported general payments places this provider in the 45th percentile of 55 urology providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 21 | $12,899 |
| Estradiol | 18 | $1,211 |
| Tamsulosin Hcl | 70 | $1,090 |
| Trospium Chloride | 12 | $511 |
| Finasteride | 27 | $359 |
| Oxybutynin Chloride ErOxybutynin Chloride | 12 | $358 |
Paid to pharmacies, not to this prescriber.
Other urology in Twin Falls
- Zachary GlaserTwin Falls$15K
- Michael SweeneyTwin Falls$5K
- Joel HancockTwin Falls$4K
- Jason GreenhalghTwin Falls$4K
- Edward MartinezTwin Falls$1K
- Jeremy WeissTwin Falls$1K
- Steven KurtzTwin Falls$623
- Nikolai SopkoTwin Falls$488
- Cory BatesTwin Falls$431
- Sean StroupBoise$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.